Yamashita K - Search Results

1

Genome-wide promoter analysis uncovers portions of the cancer methylome.

Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, Rosenbaum E, Ongenaert M, Yamashita K, Califano J, Westra W, van der Zee AG, Van Criekinge W, Sidransky D. Hoque MO, et al. Among authors: yamashita k. Cancer Res. 2008 Apr 15;68(8):2661-70. doi: 10.1158/0008-5472.CAN-07-5913. Cancer Res. 2008. PMID: 18413733 Free PMC article.

2

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D. Yamashita K, et al. Cancer Cell. 2002 Dec;2(6):485-95. doi: 10.1016/s1535-6108(02)00215-5. Cancer Cell. 2002. PMID: 12498717 Free article.

3

Re: Is TIG1 a new tumor suppressor in prostate cancer?

Tokumaru Y, Sun DI, Nomoto S, Yamashita K, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. J Natl Cancer Inst. 2003 Jun 18;95(12):919-20. doi: 10.1093/jnci/95.12.919. J Natl Cancer Inst. 2003. PMID: 12813179 No abstract available.

4

High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.

Hoque MO, Lee J, Begum S, Yamashita K, Engles JM, Schoenberg M, Westra WH, Sidransky D. Hoque MO, et al. Among authors: yamashita k. Cancer Res. 2003 Sep 15;63(18):5723-6. Cancer Res. 2003. PMID: 14522891

5

A tumor-suppressive role for trypsin in human cancer progression.

Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Cancer Res. 2003 Oct 15;63(20):6575-8. Cancer Res. 2003. PMID: 14583448

6

Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.

Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. Clin Cancer Res. 2004 Aug 15;10(16):5518-22. doi: 10.1158/1078-0432.CCR-04-0108. Clin Cancer Res. 2004. PMID: 15328191

7

Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.

Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. Cancer Res. 2004 Sep 1;64(17):5982-7. doi: 10.1158/0008-5472.CAN-04-0993. Cancer Res. 2004. PMID: 15342377

8

Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.

Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M. Utsunomiya T, et al. Among authors: yamashita k. Int J Cancer. 2005 Aug 10;116(1):105-9. doi: 10.1002/ijc.20986. Int J Cancer. 2005. PMID: 15756681

9

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.

Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D. Mandelker DL, et al. Among authors: yamashita k. Cancer Res. 2005 Jun 1;65(11):4963-8. doi: 10.1158/0008-5472.CAN-04-3923. Cancer Res. 2005. PMID: 15930319

10

p63-specific activation of the BPAG-1e promoter.

Osada M, Nagakawa Y, Park HL, Yamashita K, Wu G, Kim MS, Fomenkov A, Trink B, Sidransky D. Osada M, et al. Among authors: yamashita k. J Invest Dermatol. 2005 Jul;125(1):52-60. doi: 10.1111/j.0022-202X.2005.23801.x. J Invest Dermatol. 2005. PMID: 15982302 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,623 results

Search Page

Filters